Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Recruiting 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2CNS 1

Conditions

Neoplasms 2Brain Neoplasms 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Health Records, Personal × Clear all
NCT05102747 2026-01-27

OligoBM-01

Centre Francois Baclesse

Phase NA Recruiting
504 enrolled
CNS

Brain Neoplasms

NCT04732273 2025-09-23

SCCSS-FU

University of Bern

Recruiting
3,000 enrolled
Tumor-Agnostic

Neoplasms

NCT04811794 2022-08-17

Young Survivors at Kantonsspital Aarau, Switzerland

Kantonsspital Aarau

Recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡